SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune
If you purchased or acquired securities in Altimmune between August 10, 2023 and June 25, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
[You may also click here for additional information]
New York, New York--(Newsfile Corp. - August 10, 2025) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Altimmune, Inc. ('Altimmune' or the 'Company') (NASDAQ: ALT) and reminds investors of the October 6, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
[ This image cannot be displayed. Please visit the source: https://images.newsfilecorp.com/files/6455/261825_2d37d2d8d4d9a986_001.jpg ]
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.
According to the complaint, on June 26, 2025, Altimmune published a press release announcing topline results from the IMPACT Phase 2b MASH trial of Pemvidutide in the Treatment of MASH. While defendants had continuously provided inflated expectations ahead of these results, the analysis showed a pointed failure by the Company to achieve statistical significance in its analysis of the fibrosis reduction primary endpoint in its IMPACT Phase 2b MASH trial. In particular, while a positive trend in fibrosis improvement was observed, statistical significance was not met due to a higher-than-expected placebo response. When questioned about this concerning miss, defendants answered indifferently, attributing this result to the Phase 2 nature of the trial and stated that Altimmune was hoping for better results following the Phase 3 trial.
Following this news, the price of Altimmune's common stock declined dramatically. From a closing market price of $7.71 per share on June 25, 2025, Altimmune's stock price fell to $3.61 per share on June 26, 2025, a decline of 53.2% in the span of just a single day.
The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
Faruqi & Faruqi, LLP also encourages anyone with information regarding Altimmune's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
To learn more about the Altimmune, Inc. class action, go to www.faruqilaw.com/ALT or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
Follow us for updates on LinkedIn, on X, or on Facebook.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( www.faruqilaw.com ). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/261825
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
12 minutes ago
- Yahoo
Kodak warns it might not continue in business. Here's why.
Kodak is warning that its future in business is looking very blurry. The iconic 133-year-old business cautioned Monday that there's "substantial doubt" about its ability to continue as a going concern because it might not have the financial resources to meet its future debt obligations, according to an Aug. 11 regulatory filing. A so-called going concern warning is an accounting term that signals a risk that a business might cease operations. Shares of Kodak plunged $1.73, or 26%, to $5.05 in Tuesday morning trading. Reached for comment, a Kodak spokesperson pointed to the statement in its regulatory filing. The warning is the latest development in the photography company's storied history, which includes introducing one of the first consumer cameras in the 1880s and mass manufacturing film rolls for hobbyists and professionals alike. But Kodak struggled to adapt when digital cameras overtook film starting in the 1990s, leading to a bankruptcy filing in 2012. Its current financial crunch is tied to almost $500 million in short-term debt obligations, as well as more than $200 million in pension liabilities. Last year, Kodak had said it would end its pension plan in order to reduce debt, according to the Wall Street Journal. Kodak should have "a clear understanding by Aug.15 of how we will satisfy our obligations to all plan participants," Chief Financial Officer David Bullwinkle said in a statement, referring to the pension plan. A Kodak moment Rochester, New York-based Eastman Kodak, founded by inventor George Eastman in 1892, mass produced the famed Brownie and Instamatic cameras, popularizing photography as a pastime for generations of Americans. Its yellow-and-red film boxes were ubiquitous in photo shops and other retailers. Eastman said his goal was "to make the camera as convenient as the pencil," according to the Kodak website. But Kodak faced competition from Japanese companies, including Fujifilm in the 1990s, as well as the shift to digital technology, leading to its filing for bankruptcy protection in 2012. The company wound up selling off many of its businesses and patents, while shutting down the camera manufacturing unit that first made it famous. It received approval for its plan to emerge from court oversight a year later. At the time, Kodak was looking to recreate itself as a new, much smaller company focused on commercial and packaging printing. Kodak is now nearing completion on a manufacturing plant to create regulated pharmaceutical products. The company already makes unregulated key starting materials for pharmaceuticals. Production at the retrofitted facility is expected to start later this year. President Trump says meeting with Russia's Putin is not to broker peace deal in Ukraine Trump says he's placing D.C. police under federal control, deploying National Guard Could Tropical Storm Erin become the first Atlantic hurricane of 2025?
Yahoo
12 minutes ago
- Yahoo
Bath & Body Works opens kiosks in 600 college bookstores. See list.
It's back to school for Bath & Body Works as the company announced plans to sell its products in over 600 college campus stores for the 2025-2026 academic year. The brand's reach aims to strengthen its connection with Generation Z consumers after being named the No. 1 fragrance brand for American teens and the third overall most-shopped at beauty stores by teens in the Piper Sandler Taking Stock with Teens Spring 2025 Survey. Bath & Body Works has partnered with ICM Distributing Company to launch kiosks, working with national chains such as Barnes & Noble College and Follett-operated bookstores, as well as independent campus retailers, according to Chief Merchandising Officer Betsy Schumacher. What products will be available at college campuses? A variety of Bath & Body Works products will be available on college campuses, including body creams and lotions, fragrance mists, Wallflower diffusers, PocketBac hand sanitizers, lip products such as glosses and scrubs, hand soap and 3-wick candles, Schumacher said. Scents like Champagne Toast, Mahogany Teakwood and Clean House Vibes are standout scents and will be available in these bookstores, added Schumacher. What campuses will Bath & Body Works be available at? Bath & Body Works kiosks will be located on approximately 600 college campuses nationwide. The following 400-plus locations are at Barnes & Noble College- and Follett-owned campus bookstores, provided to USA TODAY by Bath & Body Works. The remaining locations, not included in the chart below, are independently owned bookstores. Can't see the chart in your browser? Visit Greta Cross is a national trending reporter at USA TODAY. Story idea? Email her at gcross@ This article originally appeared on USA TODAY: Bath & Body Works opens kiosks in 600 college bookstores. See list.
Yahoo
12 minutes ago
- Yahoo
Tesla To Open Austin Robotaxi Service In September
Tesla (NASDAQ:TSLA) is set to open its Austin robotaxi service to the public in September, CEO Elon Musk announced on social media. The move follows an invite-only phase that began in June with a small fleet of driverless cars and a limited user base. Warning! GuruFocus has detected 5 Warning Signs with RIVN. The company has locked in all the necessary permits to operate statewide in Texas, with approval from the Texas Department of Licensing and Regulation. It will run as a licensed Transportation Network Company through August 2026. Guggenheim's Ronald Jewsikow called the timing earlier than expected and a sign Tesla is confident in both the tech and the feedback from early riders. He said the expanded full self-driving model could bolster the bull case for Tesla's fleet eventually transitioning into robotaxis. While safety drivers will still be in place and no date has been given for their removal, he doesn't see that dampening investor enthusiasm. Tesla shares have climbed 7.5% in the past six weeks but remain more than 30% below their 52-week high. The EV maker's market cap sits at $1.09T, ranking it the 10th largest U.S. company. This article first appeared on GuruFocus.
